Verified Nov 2026
Batteries & E-Mobility
·
Florham Park, New Jersey
·
Since 2016
Celularity Inc. is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, founded in 2016 and publicly listed under the ticker CELU. It employs roughly 100 to 200 people and works in regenerative and cellular medicine, developing allogeneic, cryopreserved cell therapies and biomaterial products derived from the postpartum placenta. Its recent development includes a manufacturing collaboration announced in August 2026 with MuseCell Innovations for the Dezawa MuseCell platform in the United States. The company serves the medical, automotive, electric-vehicle, and industrial equipment sectors.
Celularity Inc. at a glance
Revenue
26.6M
Employees
100-200
Founded
2016
Headquarters
Florham Park, New Jersey
Ownership
Publicly traded (NASDAQ: CELU)
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Celularity Inc. is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, founded in 2016 and publicly listed under the ticker CELU. It employs roughly 100 to 200 people and works in regenerative and cellular medicine, developing allogeneic, cryopreserved cell therapies and biomaterial products derived from the postpartum placenta. Its recent development includes a manufacturing collaboration announced in August 2026 with MuseCell Innovations for the Dezawa MuseCell platform in the United States. The company serves the medical, automotive, electric-vehicle, and industrial equipment sectors.
At a glance
Attribute | Detail |
|---|---|
Founded | 2016 |
Headquarters | Florham Park, New Jersey |
Employees | 100-200 |
Revenue | 26.6M |
Ownership | Publicly traded (NASDAQ: CELU) |
Primary capability | Batteries & E-Mobility |
What Celularity Inc. makes
The company's cell therapy segment covers placental-derived therapies including NK cells, CAR-T cells, and mesenchymal-like adherent stromal cells, and its BioBanking segment operates LifebankUSA for storing umbilical cord and placental blood and tissue.
Latest developments
2026-09-24 — Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements | Nasdaq (nasdaq.com)
2026-08-27 — Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform (businesswire.com)
2026-04-21 — NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment :: NEXGEL, Inc. (NXGL) (nexgel.com)
2026-03-10 — Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy – Celularity (celularity.com)
2025-12-18 — Celularity Reaches Binding Term Sheets on Financing Transactions to Support Its Strategic Vision – Celularity (celularity.com)
2025-10-30 — Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care – Celularity (celularity.com)
Company details
The company reports a portfolio of over 800 patents and trades publicly under the ticker CELU, with a reported revenue band of about $26.6 million. Celularity Inc. was founded in 2016, has an estimated 100-200 employees, and is headquartered in Florham Park, New Jersey.
Frequently asked questions
What does Celularity Inc. make?
Celularity Inc. is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, founded in 2016 and publicly listed under the ticker CELU. It employs roughly 100 to 200 people and works in regenerative and cellular medicine, developing allogeneic, cryopreserved cell therapies and biomaterial products derived from the postpartum placenta. Its recent development includes a manufacturing collaboration announced in August 2026 with MuseCell Innovations for the Dezawa MuseCell platform in the United States. The company serves the medical, automotive, electric-vehicle, and industrial equipment sectors.
Where is Celularity Inc. headquartered?
Celularity Inc. is headquartered in Florham Park, New Jersey (170 Park Ave, Florham Park, New Jersey, 07932-1049).
When was Celularity Inc. founded?
Celularity Inc. was founded in 2016.
How big is Celularity Inc.?
Celularity Inc. has an estimated 100-200 employees, with revenue in the 26.6M range.
Is Celularity Inc. publicly traded?
Publicly traded (NASDAQ: CELU). Public financial figures are drawn from its filings.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.